Review

. 2021 Jun 8;16(6):1398-1408.

doi: 10.1016/j.stemcr.2021.05.012. Epub 2021 May 27.

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

Robin Lovell-Badge¹, Eric Anthony², Roger A Barker³, Tania Bubela⁴, Ali H Brivanlou⁵, Melissa Carpenter⁶, R Alta Charo⁷, Amander Clark⁸, Ellen Clayton⁹, Yali Cong¹⁰, George Q Daley¹¹, Jianping Fu¹², Misao Fujita¹³, Andy Greenfield¹⁴, Steve A Goldman¹⁵, Lori Hill¹⁶, Insoo Hyun¹⁷, Rosario Isasi¹⁸, Jeffrey Kahn¹⁹, Kazuto Kato²⁰, Jin-Soo Kim²¹, Jonathan Kimmelman²², Jürgen A Knoblich²³, Debra Mathews¹⁹, Nuria Montserrat²⁴, Jack Mosher², Megan Munsie²⁵, Hiromitsu Nakauchi²⁶, Luigi Naldini²⁷, Gail Naughton²⁸, Kathy Niakan²⁹, Ubaka Ogbogu³⁰, Roger Pedersen³¹, Nicolas Rivron²³, Heather Rooke³², Janet Rossant³³, Jeff Round³⁴, Mitinori Saitou¹³, Douglas Sipp³⁵, Julie Steffann³⁶, Jeremy Sugarman¹⁹, Azim Surani³⁷, Jun Takahashi¹³, Fuchou Tang¹⁰, Leigh Turner³⁸, Patricia J Zettler³⁹, Xiaomei Zhai⁴⁰

Affiliations

¹ Francis Crick Institute, London, UK. Electronic address: robin.lovell-badge@crick.ac.uk.
² International Society for Stem Cell Research, Skokie, IL, USA.
³ Cambridge Center for Brain Repair and WT-MRC Stem Cell Institute, Cambridge, UK.
⁴ Simon Fraser University, Burnaby, BC, Canada.
⁵ The Rockefeller University, New York, NY, USA.
⁶ ElevateBio/Carpenter Group Consulting, Waltham, MA, USA.
⁷ University of Wisconsin-Madison, Madison, WI, USA.
⁸ University of California, Los Angeles, Los Angeles, CA, USA.
⁹ Vanderbilt University, Nashville, TN, USA.
¹⁰ Peking University, Beijing, China.
¹¹ Harvard Medical School, Boston, MA, USA.
¹² University of Michigan, Ann Arbor, MI USA.
¹³ Kyoto University, Kyoto, Japan.
¹⁴ MRC Harwell Institute, Oxfordshire, UK.
¹⁵ University of Rochester Medical Center, Rochester, NY, USA; University of Copenhagen, Copenhagen, Denmark.
¹⁶ MD Anderson, Houston, TX, USA.
¹⁷ Harvard Medical School, Boston, MA, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
¹⁸ University of Miami, Coral Gables, FL, USA.
¹⁹ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
²⁰ Osaka University, Suita, Japan.
²¹ Seoul National University, Seoul, Korea.
²² McGill University, Montreal, QC, Canada.
²³ IMBA-Institute of Molecular Biotechnology, Vienna, Austria.
²⁴ Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
²⁵ University of Melbourne, Melbourne, VIC, Australia.
²⁶ Stanford University, Stanford, CA, USA; University of Tokyo, Tokyo, Japan.
²⁷ Università Vita-Salute San Raffaele, Milan, Italy.
²⁸ Histogen, San Diego, CA, USA.
²⁹ Francis Crick Institute, London, UK; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.
³⁰ University of Alberta, Edmonton, AB, Canada.
³¹ Stanford University, Stanford, CA, USA.
³² Broad Institute, Cambridge, MA, USA.
³³ Gairdner Foundation/SickKids, Toronto, ON, Canada.
³⁴ Institute of Health Economics, Edmonton, AB, Canada.
³⁵ RIKEN Center for Developmental Biology, Wako, Japan; Keio University School of Medicine, Tokyo, Japan.
³⁶ Université Paris Descartes, Paris, France.
³⁷ Gurdon Institute, University of Cambridge, Cambridge, UK.
³⁸ University of Minnesota, Minneapolis, MN, USA.
³⁹ Ohio State University, Columbus, OH, USA.
⁴⁰ Peking Union Medical College, Beijing, China.

PMID: 34048692
PMCID: PMC8190668
DOI: 10.1016/j.stemcr.2021.05.012

Review

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

Robin Lovell-Badge et al. Stem Cell Reports. 2021.

. 2021 Jun 8;16(6):1398-1408.

doi: 10.1016/j.stemcr.2021.05.012. Epub 2021 May 27.

Authors

Affiliations

¹ Francis Crick Institute, London, UK. Electronic address: robin.lovell-badge@crick.ac.uk.
² International Society for Stem Cell Research, Skokie, IL, USA.
³ Cambridge Center for Brain Repair and WT-MRC Stem Cell Institute, Cambridge, UK.
⁴ Simon Fraser University, Burnaby, BC, Canada.
⁵ The Rockefeller University, New York, NY, USA.
⁶ ElevateBio/Carpenter Group Consulting, Waltham, MA, USA.
⁷ University of Wisconsin-Madison, Madison, WI, USA.
⁸ University of California, Los Angeles, Los Angeles, CA, USA.
⁹ Vanderbilt University, Nashville, TN, USA.
¹⁰ Peking University, Beijing, China.
¹¹ Harvard Medical School, Boston, MA, USA.
¹² University of Michigan, Ann Arbor, MI USA.
¹³ Kyoto University, Kyoto, Japan.
¹⁴ MRC Harwell Institute, Oxfordshire, UK.
¹⁵ University of Rochester Medical Center, Rochester, NY, USA; University of Copenhagen, Copenhagen, Denmark.
¹⁶ MD Anderson, Houston, TX, USA.
¹⁷ Harvard Medical School, Boston, MA, USA; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
¹⁸ University of Miami, Coral Gables, FL, USA.
¹⁹ Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA.
²⁰ Osaka University, Suita, Japan.
²¹ Seoul National University, Seoul, Korea.
²² McGill University, Montreal, QC, Canada.
²³ IMBA-Institute of Molecular Biotechnology, Vienna, Austria.
²⁴ Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
²⁵ University of Melbourne, Melbourne, VIC, Australia.
²⁶ Stanford University, Stanford, CA, USA; University of Tokyo, Tokyo, Japan.
²⁷ Università Vita-Salute San Raffaele, Milan, Italy.
²⁸ Histogen, San Diego, CA, USA.
²⁹ Francis Crick Institute, London, UK; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK.
³⁰ University of Alberta, Edmonton, AB, Canada.
³¹ Stanford University, Stanford, CA, USA.
³² Broad Institute, Cambridge, MA, USA.
³³ Gairdner Foundation/SickKids, Toronto, ON, Canada.
³⁴ Institute of Health Economics, Edmonton, AB, Canada.
³⁵ RIKEN Center for Developmental Biology, Wako, Japan; Keio University School of Medicine, Tokyo, Japan.
³⁶ Université Paris Descartes, Paris, France.
³⁷ Gurdon Institute, University of Cambridge, Cambridge, UK.
³⁸ University of Minnesota, Minneapolis, MN, USA.
³⁹ Ohio State University, Columbus, OH, USA.
⁴⁰ Peking Union Medical College, Beijing, China.

PMID: 34048692
PMCID: PMC8190668
DOI: 10.1016/j.stemcr.2021.05.012

Abstract

The International Society for Stem Cell Research has updated its Guidelines for Stem Cell Research and Clinical Translation in order to address advances in stem cell science and other relevant fields, together with the associated ethical, social, and policy issues that have arisen since the last update in 2016. While growing to encompass the evolving science, clinical applications of stem cells, and the increasingly complex implications of stem cell research for society, the basic principles underlying the Guidelines remain unchanged, and they will continue to serve as the standard for the field and as a resource for scientists, regulators, funders, physicians, and members of the public, including patients. A summary of the key updates and issues is presented here.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests R.L.-B. has no financial conflicts to declare. R.L.-B. serves on the following advisory boards: Scientific and Clinical Advances Advisory Committee of the Human Fertility and Embryo Authority; Sense About Science, Member of Board of Trustees; Public Library of Science (PLOS), Board Member, Chair of Audit Committee, Chair of Remunerations Committee, and member of Scientific Advisory Board; Royal Society, Chair of “Genetic Technologies Programme,” Progress Educational Trust, Chair of the Board of Trustees; member of the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing; Chair of ISSCR Task Force to Update the Guidelines; and member of External Advisory Board, “Cambridge Reproduction Strategic Research Initiative,” University of Cambridge, UK. R.B. receives funding from UK NIHR, MRC, Wellcome, Cure Parkinson’s Trust, and EU. R.B. received funding from Parkinson’s UK, CHDI, Rosetrees Trust, and Evelyn Trust. R.B. receives royalties from Wiley and Springer and also has an ongoing consultancy role for the following companies: Novo Nordisk, UCB, Aspen Neuroscience, and BlueRock Therapeutics. A.H.B. is a co-founder of OvaNova, Inc., as well as a co-founder of Rumi Scientific, Inc. R.A.C. is Professor Emerita, University of Wisconsin; David Hamburg Fellow, Nuclear Threat Initiative; and Lead Co-Chair, BioMADE. R.A.C is a member of the WHO Expert Advisory Group on Genome Editing; member of the Planning Committee, Third International Summit on Genome Editing; and Co-Chair of the US National Academy of Medicine committee on emerging science, technology, and innovation. A.C. is a board member of the ISSCR and scientific advisory board member of the Tepper Foundation. G.Q.D. holds patents relevant to stem cells and is a founder of and member of the scientific advisory board of 28/7 Therapeutics, Inc. S.G. is also a part-time employee and stock-holder of Sana Biotechnology, a cell therapy company; he holds relevant patents and his lab receives sponsored research support from Sana. A.G. is a current or recent board member of the following: the National Academies International Commission on Heritable Human Genome Editing; the UK HFEA’s Scientific & Clinical Advances Advisory Committee; and the UK Nuffield Council on Bioethics until 2020. A.G.’s core funding is from the Mammalian Genetics Unit at MRC Harwell (MC_U142684167). J.K. holds a patent on the cerebral organoid method and is co-founder and scientific advisory board member of a:head bio. D.J.H.M. is a member of the Maryland Stem Cell Research Commission and a paid Academic Collaborator of the National Academy of Medicine’s Committee on Emerging Science, Technology, and Innovation in health and medicine. L.N. is an inventor on patents on lentiviral vector technology and targeted genome editing filed by Telethon Foundation and/or San Raffaele Scientific Institute. L.N. is a founder and/or owns equity and is a scientific advisory board member of Genenta Science, Magenta Therapeutics, Genespire, and Tessera. R.P. is an advisor and has stock options in BIT BIO. J.R. is a member, Board of Directors, Notch Therapeutics; member, Editorial Board, Stem Cell Reports; and member, Editorial Board, Cell Stem Cell. N.R. is an inventor on two patents describing the blastoid technology (EP2986711 and EP21151455.9). N.R. has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program ERC-Co grant agreement no. 101002317. M.S. is affiliated with the following: Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Department of Anatomy and Cell Biology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; and Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. M.S. is an inventor on patent applications relating to the induction of germ cells from PSCs filed by Kyoto University. J.S. is a member of Merck KGaA’s Bioethics Advisory Panel and Stem Cell Research Oversight Committee; a member of IQVIA’s Ethics Advisory Panel; a member of Aspen Neurosciences Scientific Advisory Board; a member of a Merck Data Monitoring Committee; a consultant to Biogen; and a consultant to Portola Pharmaceuticals, Inc. L.T. has no financial interests to declare. L.T. is member of ISSCR’s Ethics Committee and Membership Committee and was a member of one of the working groups involved in revising and updating ISSCR’s guidance document. The other authors declare no competing interests.

Cited by

Single-cell analysis of embryoids reveals lineage diversification roadmaps of early human development.
Zheng Y, Yan RZ, Sun S, Kobayashi M, Xiang L, Yang R, Goedel A, Kang Y, Xue X, Esfahani SN, Liu Y, Resto Irizarry AM, Wu W, Li Y, Ji W, Niu Y, Chien KR, Li T, Shioda T, Fu J. Zheng Y, et al. Cell Stem Cell. 2022 Sep 1;29(9):1402-1419.e8. doi: 10.1016/j.stem.2022.08.009. Cell Stem Cell. 2022. PMID: 36055194 Free PMC article.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modeling.
Juguilon C, Wu JC. Juguilon C, et al. Dis Model Mech. 2024 Jul 1;17(7):dmm050947. doi: 10.1242/dmm.050947. Epub 2024 Jul 8. Dis Model Mech. 2024. PMID: 38973350 Free PMC article.
Evidence generation and reproducibility in cell and gene therapy research: A call to action.
Abou-El-Enein M, Angelis A, Appelbaum FR, Andrews NC, Bates SE, Bierman AS, Brenner MK, Cavazzana M, Caligiuri MA, Clevers H, Cooke E, Daley GQ, Dzau VJ, Ellis LM, Fineberg HV, Goldstein LSB, Gottschalk S, Hamburg MA, Ingber DE, Kohn DB, Krainer AR, Maus MV, Marks P, Mummery CL, Pettigrew RI, Rutter JL, Teichmann SA, Terzic A, Urnov FD, Williams DA, Wolchok JD, Lawler M, Turtle CJ, Bauer G, Ioannidis JPA. Abou-El-Enein M, et al. Mol Ther Methods Clin Dev. 2021 Jul 21;22:11-14. doi: 10.1016/j.omtm.2021.06.012. eCollection 2021 Sep 10. Mol Ther Methods Clin Dev. 2021. PMID: 34377737 Free PMC article. No abstract available.
Organoids in skin wound healing.
Wang Z, Zhao F, Lang H, Ren H, Zhang Q, Huang X, He C, Xu C, Tan C, Ma J, Duan S, Wang Z. Wang Z, et al. Burns Trauma. 2025 Jan 3;13:tkae077. doi: 10.1093/burnst/tkae077. eCollection 2025. Burns Trauma. 2025. PMID: 39759541 Free PMC article. Review.
Factors associated with knowledge and practice of breast self-examination among female governmental school teachers in Gondar Town, Northwest Ethiopia, 2019.
Yazew BG, Alemu BW, Walle TA. Yazew BG, et al. Front Oncol. 2024 Dec 24;14:1481714. doi: 10.3389/fonc.2024.1481714. eCollection 2024. Front Oncol. 2024. PMID: 39777343 Free PMC article.

See all "Cited by" articles

References

1. Clark A., Brivanolou A., Fu J., Kato K., Mathews D., Niakan K., Rivron N., Saitou M., Surani A., Tang F., Rossant J. Human embryo research, stem cell-derived embryo models and in vitro gametogenesis: considerations leading to the revised ISSCR guidelines. Stem Cell Reports. 2021 doi: 10.1016/j.stemcr.2021.05.008. - DOI - PMC - PubMed
1. Daley G.Q., Ahrlund Richter L., Auerbach J.M., Benvenisty N., Charo R.A., Chen G., Deng H.K., Goldstein L.S., Hudson K.L., Hyun I. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science. 2007;315:603–604. doi: 10.1126/science.1139337. - DOI - PubMed
1. Daley G.Q., Hyun I., Apperley J.F., Barker R.A., Benvenisty N., Bredenoord A.L., Breuer C.K., Caulfield T., Cedars M.I., Frey-Vasconcells J. Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Stem Cell Reports. 2016;6:787–797. doi: 10.1016/j.stemcr.2016.05.001. - DOI - PMC - PubMed
1. Deglincerti A., Croft G.F., Pietila L.N., Zernicka-Goetz M., Siggia E.D., Brivanlou A.H. Self-organization of the in vitro attached human embryo. Nature. 2016;533:251–254. doi: 10.1038/nature17948. - DOI - PubMed
1. Doudna J.A. The promise and challenge of therapeutic genome editing. Nature. 2020;578:229–236. doi: 10.1038/s41586-020-1978-5. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

Affiliations

ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical